BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15316615)

  • 1. [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature].
    Wasser K; Giebel F; Fischbach R; Tesch H; Landwehr P
    Radiologe; 2005 Jul; 45(7):633-43. PubMed ID: 15316615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study.
    Nishiofuku H; Tanaka T; Matsuoka M; Otsuji T; Anai H; Sueyoshi S; Inaba Y; Koyama F; Sho M; Nakajima Y; Kichikawa K
    J Vasc Interv Radiol; 2013 Jan; 24(1):56-65. PubMed ID: 23194749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
    Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
    Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis.
    Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K
    Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.
    Massmann A; Rodt T; Marquardt S; Seidel R; Thomas K; Wacker F; Richter GM; Kauczor HU; Bücker A; Pereira PL; Sommer CM
    Langenbecks Arch Surg; 2015 Aug; 400(6):641-59. PubMed ID: 26088872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
    Gross A; Albrecht T
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):402-410. PubMed ID: 31705244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer].
    Itani K; Yoshikawa T; Oyamada H; Takano H; Ichikawa H; Tainaka K; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2897-900. PubMed ID: 2506828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer].
    Hirasawa T; Asahara S; Fujisaki S; Kuraoka K; Takano K; Kamei A; Ikari T
    Nihon Shokakibyo Gakkai Zasshi; 2008 Mar; 105(3):367-72. PubMed ID: 18332601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
    Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.
    Vogl TJ; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Trojan J; Zangos S; Naguib NN
    Eur J Radiol; 2013 Feb; 82(2):258-63. PubMed ID: 23127803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
    Morise Z; Sugioka A; Kato R; Fujita J; Hoshimoto S; Kato T
    J Gastrointest Surg; 2006 Feb; 10(2):249-58. PubMed ID: 16455458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
    Iezzi R; Pompili M; Rinninella E; Annicchiarico E; Garcovich M; Cerrito L; Ponziani F; De Gaetano A; Siciliano M; Basso M; Zocco MA; Rapaccini G; Posa A; Carchesio F; Biolato M; Giuliante F; Gasbarrini A; Manfredi R;
    Eur Radiol; 2019 Mar; 29(3):1285-1292. PubMed ID: 30171360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
    BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
    Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma.
    Auer TA; Jonczyk M; Collettini F; Marth A; Wieners G; Hamm B; Gebauer B
    Acta Radiol; 2021 Mar; 62(3):313-321. PubMed ID: 32498543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
    Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
    Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregated time intensity curves after transarterial chemoembolization with degradable starch microspheres: a feasibility study.
    Heibl M; Jung EM; Beyer L; Wohlgemuth WA; Stroszczynski C; Wiggermann P
    Clin Hemorheol Microcirc; 2013 Jan; 55(4):417-21. PubMed ID: 24113498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.